In this project, we will define the cellular and molecular mechanisms by which NLRP2 regulates innate and adaptive immune signaling during bacterial infection. To this end, we generated mice with a conditionally targeted deletion of NLRP2. These studies will help to uncover novel signaling pathways that can be therapeutically targeted to treat infectious and inflammatory diseases.